There’s one place where bundled solutions don’t add up.
Cardiovascular disease is the biggest, deadliest and costliest health problem facing American workers. A problem of this level requires a best-in-class heart health solution proven to deliver big health outcomes and significant cost savings.
There’s one place where bundled solutions don’t add up.
Bundled digital health solutions can’t compare.
21
66
67
10
64
13
40
13
21
19
66
67
10
64
13
40
13
*References for studies involving non-Hello Heart solutions are available upon request and are not listed here for the purposes of anonymity.
Unmatched heart health outcomes.
A peer-reviewed study published in JAMA Open Network shows how our members achieve big drops in blood pressure, which dramatically lowers the risk of stroke and heart attacks.
Decrease high-cost claims.
Hello Heart users had 3.8 fewer inpatient days in the hospital, while non-users had an increase of nearly 10 days. You can read all the details in the Validation Institute's report that shows how you can achieve meaningful ROI with our program.
Engagement among the hardest to reach.
Hello Heart’s digital-only approach has shown high engagement and meaningful clinical outcomes across social determinants of health - age, gender, language, income, access to healthcare facilities and race / ethnicity.
Partnering with us is easy.
Work with a partner that takes the complexity off of your clients.
Hello Heart offers:
We work with great companies.
Tracking, detection, coaching, and more.
Health metric tracking
Measure blood pressure, cholesterol, medication, activity, and weight
Risk detection
Members get flags for abnormal readings
Personalized coaching
Personal insights based on clinical guidelines
Health equity
Sensitive to age and gender differences
Clinical reports
Detailed reports for clinicians for better care
Request a demo
Your request has been received!
- Gazit T, et al. JAMA Netw Open. 2021; 4(10). (Some study authors were employed by Hello Heart. Due to study design, causal conclusions cannot be made. There were 108 participants with baseline blood pressure over 140/90 enrolled for 3 years. 84% lowered their SBP.)
- Paz E, et al. J Am Heart Assoc. 2024;13(10). (Some study authors were employed by Hello Heart. Due to study design, causal conclusions cannot be made. There were 109 participants with baseline TC ≥240 mg/dL, 84% of whom reduced TC at an average of 13 mos. There were 99 participants with baseline LDL-C ≥ 160mg/dL, 80% of whom reduced LDL-C at an average of 13 mos.)
- Ettehad D, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. The Lancet. 2016;387(10022): 957-967.
- Based on internal data analyzed by Hello Heart. Not yet subject to peer review.
